Medipharm Labs CFO Resigns From Company For Family Reasons

Medipharm Labs (TSX: LABS) this morning announced changes to their leadership team within a brief news release that was issued. The company has revealed that current chief financial officer Robert (Bobby) Kwon has resigned from the company just barely a year after taking on the role.

Appointed to the position last November, Kwon effectively took over the role on November 18, 2019. At the time, he was hyped as being a highly experienced executive from the consumer packaged goods, retail and pharmaceutical industries with over twenty five years of experience.

Kwon is said to be leaving for family reasons, with his official departure taking place at the end of the month. An interim CFO is expected to fulfill the role until a permanent replacement can be found, with the search beginning immediately. Neither an interim or permanent replacement was named in this mornings announcement.

A further announcement with respect to the interim appointee is expected to be made at the end of the month.

Medipharm Labs last traded at $0.78 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

MediPharm Labs: Canaccord Slashes Price Target Following Q4 Results

Earlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial...

Friday, April 2, 2021, 09:00:00 AM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM

Public Cannabis Companies Have Already Received More Than $25 Million in Federal Wage Subsidies

In response to the spread of COVID-19, the Canadian Federal Government introduced several programs to...

Saturday, November 14, 2020, 10:00:00 AM

Medipharm Labs Receives Australian Drug Import License

Medipharm Labs (TSX: LABS) announced this morning that the firm has received an importation license...

Friday, January 31, 2020, 09:04:16 AM

Rough Week In Cannabis Sector Capped With Gut Punch From Ontario

This first week of April has been the never-ending week for the cannabis industry that...

Friday, April 3, 2020, 03:24:27 PM